Abstracts tagged "Fractures and rheumatoid arthritis (RA)"

Abstract Number: 348 • 2016 ACR/ARHP Annual Meeting
Bisphosphonates-Related Atypical Femur Fractures: 8 Years’ Experience in a Single Center
JungHee Koh¹, Seo Hwa Kim², Haneul Kim³, Min Kyung Chung³, Ji Hyeon Ju⁴ and Sung-Hwan Park⁴, ¹Seochogu, Banpodaero, 222, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ²Division of Rheumatology,, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ³Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ⁴Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea
Background/Purpose: Patients with rheumatoid arthritis (RA) are diagnosed with osteoporosis earlier than those without, and are therefore exposed to bisphosphonates for longer. However, the increasing…
Abstract Number: 383 • 2013 ACR/ARHP Annual Meeting
Increased Incidence Of Low-Energy Fractures In Rheumatoid Arthritis Patients
Kristina Wiberg¹, Marie-Louise Öhman², Ulrika Bergström³ and Solbritt M. Rantapaa-Dahlqvist⁴, ¹Institution of Public Helath & Clinical Medicin, Rheumatology, Umeå University, Umeå, Sweden, ²Institution of Public Health & Clinical Medicin, Rheumatology, Umeå University, Umeå, Sweden, ³Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden, ⁴Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, Umea, Sweden
Background/Purpose: Patients with rheumatoid arthritis (RA) have increased development of osteoporosis. The fracture indicence is not well explored. The aim of this study was to…
Abstract Number: 1963 • 2012 ACR/ARHP Annual Meeting
Fracture Sites, Frequencies and Causes in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study
Kensuke Ochi¹, Takefumi Furuya², Eisuke Inoue³, Katsunori Ikari⁴, Atsuo Taniguchi³, Shigeki Momohara⁴ and Hisashi Yamanaka², ¹Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ³Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ⁴Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Although rheumatoid arthritis (RA) is a risk factor for osteoporosis and fracture, limited data exist in the literature concerning fracture site and frequency in…
Abstract Number: 1013 • 2012 ACR/ARHP Annual Meeting
The Influence of Vertebral Fractures On the Functional Disability of Patients with Rheumatoid Arthritis
Soo-Kyung Cho¹, Joo-Hyun Lee², Min-Kyung Han³, Seunghun Lee⁴, Ji Young Kim⁵, Jeong Ah Ryu⁶, Yun Young Choi⁵, Sang-Cheol Bae⁷ and Yoon-Kyoung Sung⁸, ¹Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ²Department of Rheumatology, Ilsan Paik Hospital, Inje University, Goyang, South Korea, ³Department of Rheumatology, Hanyang University Hospital for Rheumatic Disease, Seoul, South Korea, ⁴Department of Radiology, Department of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁵Department of Nuclear Medicine, Hanyang University College of Medicine, Seoul, South Korea, ⁶Department of Radiology, Hanyang University College of Medicine, Seoul, South Korea, ⁷Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ⁸Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea
Background/Purpose: Rheumatoid arthritis (RA) is a chronic, painful, and disabling disease associated with reduced health-related quality of life (HRQOL) compared to the general population. Higher…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].